MGlu2-Agonisten
European patent · EP2516406 · In force
Register entry
- Publication number
- EP2516406
- Application number
- EP10798419
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Dec 15, 2010
- Published
- Oct 31, 2012
- Granted
- Sep 18, 2013
- Protection ends at the latest
- Dec 14, 2030
- Next annual fee due
- Dec 31, 2026
- IPC classes
- C07D 249/10 (2006.01)A61K 31/4196 (2006.01)A61P 25/00 (2006.01)
- Priority
- US 305239 P 17.02.2010EP 09382290 21.12.2009
- PCT application
- PCT/US2010/060371 15.12.2010
- PCT publication
- WO2011/084437 14.07.2011
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 1, 2026
Change
Published in Swissreg on 01.01.2026
- Jan 1, 2025
Change
Published in Swissreg on 01.01.2025
- Jan 1, 2024
Change
Published in Swissreg on 01.01.2024
- Dec 21, 2023
Address changed
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich
Published in Swissreg on 21.12.2023
- Jan 1, 2023
Change
Published in Swissreg on 01.01.2023
- Oct 1, 2013
Agent entered
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich
Published in Swissreg on 01.10.2013
- Sep 18, 2013
Granted
Published in Swissreg on 18.09.2013
Parties
Inventor
Indianapolis, Indiana 46285, US
Indianapolis, Indiana 46285, US
Indianapolis, Indiana 46285, US
Indianapolis, Indiana 46285, US
Indianapolis, Indiana 46285, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.